Effectiveness of aprepitant in post-acute COVID19 syndrome

Reinoso-Arija, Rocío; López-Ramírez, Cecilia; Jimenez-Ruiz, José Antonio; López-Campos, José Luis

Publication:
Effectiveness of aprepitant in post-acute COVID19 syndrome

dc.contributor.author	Reinoso-Arija, Rocío
dc.contributor.author	López-Ramírez, Cecilia
dc.contributor.author	Jimenez-Ruiz, José Antonio
dc.contributor.author	López-Campos, José Luis
dc.contributor.authoraffiliation	[Reinoso-Arija,R; López-Ramírez,C; López-Campos,JL] Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/ Universidad de Sevilla, Sevilla, Spain. [López-Campos,JL] Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. [Jimenez-Ruiz,JA] Research Group on Electronic Technology and Industrial Computing (TIC-150), University of Sevilla, Sevilla, Spain.
dc.date.accessioned	2022-08-26T12:33:03Z
dc.date.available	2022-08-26T12:33:03Z
dc.date.issued	2021-09-18
dc.description.abstract	This is the first case of a patient taking aprepitant for a post-acute COVID-19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome.	es_ES
dc.description.version	Yes	es_ES
dc.identifier.citation	Reinoso-Arija R, López-Ramírez C, Jimenez-Ruiz JA, López-Campos JL. Effectiveness of aprepitant in post-acute COVID19 syndrome. Clin Case Rep. 2021 Sep 18;9(9):e04646	es_ES
dc.identifier.doi	10.1002/ccr3.4646	es_ES
dc.identifier.essn	2050-0904
dc.identifier.pmc	PMC8449093
dc.identifier.pmid	34567551	es_ES
dc.identifier.uri	http://hdl.handle.net/10668/3958
dc.journal.title	Clinical Case Reports
dc.language.iso	en
dc.page.number	4 p.
dc.publisher	John Wiley & Sons Ltd	es_ES
dc.relation.publisherversion	https://onlinelibrary.wiley.com/doi/10.1002/ccr3.4646	es_ES
dc.rights	Atribución-NoComercial 4.0 Internacional	*
dc.rights	Atribución-NoComercial 4.0 Internacional	*
dc.rights.accessRights	open access
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/	*
dc.subject	Aprepitant	es_ES
dc.subject	Post-acute	es_ES
dc.subject	COVID19	es_ES
dc.subject	SARS-CoV-2	es_ES
dc.subject	Atención subaguda	es_ES
dc.subject	Infecciones por coronavirus	es_ES
dc.subject	Síndrome	es_ES
dc.subject	Salud	es_ES
dc.subject.mesh	Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Neurokinin-1 Receptor Antagonists	es_ES
dc.subject.mesh	Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans	es_ES
dc.subject.mesh	Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::Nausea	es_ES
dc.subject.mesh	Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::Vomiting	es_ES
dc.subject.mesh	Medical Subject Headings::Persons::Persons::Age Groups::Adult	es_ES
dc.subject.mesh	Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections	es_ES
dc.subject.mesh	Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::Pandemics	es_ES
dc.subject.mesh	Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation	es_ES
dc.subject.mesh	Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Clinical Laboratory Techniques::Immunologic Tests::Serologic Tests	es_ES
dc.title	Effectiveness of aprepitant in post-acute COVID19 syndrome	es_ES
dc.type	research article
dc.type.hasVersion	VoR
dspace.entity.type	Publication